TARGRETIN: payments to doctors
Payments that named TARGRETIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $200K
- Providers
- 1,503
- Transactions
- 4,493
- Average per transaction
- $44
The per-transaction average — $44 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,503 providers the average total is $133, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $188,453 | 94.3% |
| Bausch Health US, LLC | $11,240 | 5.6% |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $93 | 0.0% |